Volume 117, Issue 1, Pages (July 1999)

Slides:



Advertisements
Similar presentations
DrMohammadSadrkabir Editor:. FREQUENCY OF ELEVATED HEPATOCELLULAR CARCINOMA (HCC) BIOMARKERS IN PATIENTS WITH ADVANCED HEPATITIS C The American Journal.
Advertisements

Functional Analysis of the Neurofibromatosis Type 2 Protein by Means of Disease- Causing Point Mutations Renee P. Stokowski, David R. Cox The American.
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Genetic testing for high-risk colon cancer patients1 William M. Grady Gastroenterology Volume 124, Issue 6, Pages (May 2003) DOI: /S (03)
Celiac Disease Genetics: Current Concepts and Practical Applications Ludvig M. Sollid, Benedicte A. Lie Clinical Gastroenterology and Hepatology Volume.
Serum immunoglobulin a from patients with celiac disease inhibits human T84 intestinal crypt epithelial cell differentiation Tuula Halttunen, Markku Mäki.
Volume 63, Issue 1, Pages (July 2015)
Risk Factors for Hepatocellular Carcinoma in Patients With Alcoholic or Viral C Cirrhosis  Gisèle N’Kontchou, Jacques Paries, Myint Tin Tin Htar, Nathalie.
Volume 46, Issue 3, Pages (March 2007)
Masatoshi Kudo  Clinical Gastroenterology and Hepatology 
It's time to bring the best and brightest back to gastroenterology!
Prognosis following spontaneous HBsAg seroclearance in chronic hepatitis B patients with or without concurrent infection  Yi–Cheng Chen, I.–Shyan Sheen,
Abnormal Liver Tests and Fatty Liver on Ultrasound
The prevalence of alcohol-induced liver disease and hepatitis C and their interaction in a tertiary care setting  Adnan Said, John Williams, Jeremy Holden,
From Fat to Inflammation
Les Lang  Gastroenterology  Volume 133, Issue 1, (July 2007)
Les Lang  Gastroenterology  Volume 133, Issue 1, (July 2007)
Diagnosis of celiac sprue
Leptin, obesity, and liver disease
Covering the Cover Gastroenterology
The prevalence of alcohol-induced liver disease and hepatitis C and their interaction in a tertiary care setting  Adnan Said, John Williams, Jeremy Holden,
Volume 136, Issue 1, Pages (January 2009)
Individualized prediction of hepatocellular carcinoma occurrence in a large cohort of patients with cirrhosis  Astrid Marot, Jean Henrion, Jean-François.
Hepatocellular Carcinoma in Adults and Children
Hepatitis B and C virus-related carcinogenesis
Ira J. Fox, Stephen C. Strom  Gastroenterology 
Volume 123, Issue 1, Pages (July 2002)
Hepatocellular Carcinoma in Patients With Cryptogenic Cirrhosis
Covering the Cover Gastroenterology
Cheng-Yuan Peng, Rong-Nan Chien, Yun-Fan Liaw  Journal of Hepatology 
European Association for the Study of the Liver  Journal of Hepatology 
Volume 68, Issue 1, Pages (January 2018)
Genetics of Colonic Polyposis
Example of algorithm for clinical assessment of patients at risk of non-alcoholic fatty liver disease Example of algorithm for clinical assessment.
Hepatitis C and Hepatocellular Carcinoma: Grist for the Mill
Incidence of Statin Hepatotoxicity in Patients With Hepatitis C
Michael Charlton  Clinical Gastroenterology and Hepatology 
Genomic risk of hepatitis C-related hepatocellular carcinoma
Autophagy in the liver Journal of Hepatology
Volume 122, Issue 2, Pages (February 2002)
Volume 116, Issue 1, Pages (January 1999)
Hypothyroidism: A Possible Risk Factor for Liver Cancer in Patients With No Known Underlying Cause of Liver Disease  Arvind Reddy, Chiranjeev Dash, Apinya.
Example of algorithm for clinical assessment of patients at risk of non-alcoholic fatty liver disease Example of algorithm for clinical assessment.
Abnormal Liver Tests and Fatty Liver on Ultrasound
Hepatitis B and C virus-related carcinogenesis
Effects of Serum Aspartate Aminotransferase Levels in Patients With Autoimmune Hepatitis Influence Disease Course and Outcome  Thawab Al–Chalabi, James.
Volume 133, Issue 2, Pages (August 2007)
AGA technical review on nonalcoholic fatty liver disease
Hepatic Dysfunction in Sickle Cell Disease: A New System of Classification Based on Global Assessment  Philip A. Berry, Timothy J.S. Cross, Swee Lay Thein,
Jeremy P. Dwyer, Patrick Hosking, John Lubel  Gastroenterology 
Volume 149, Issue 6, Pages (November 2015)
Kornelius Schulze, Jean-Charles Nault, Augusto Villanueva 
Volume 17, Issue 2, Pages (February 1950)
Volume 63, Issue 1, Pages (July 2015)
Integrating sorafenib into an algorithm for the management of post-transplant hepatocellular carcinoma recurrence  Christian Toso, Gilles Mentha, Pietro.
AGA technical review on osteoporosis in gastrointestinal diseases
Volume 122, Issue 4, Pages (April 2002)
Liver Transplantation for Hepatocellular Carcinoma
Hepatitis C Virus Infection, Age, and Hispanic Ethnicity Increase Mortality From Liver Cancer in the United States  Zobair M. Younossi, Maria Stepanova 
Michelle Maria Pietzak  Gastroenterology 
Eldad S. Bialecki, Amobi M. Ezenekwe, Elizabeth M. Brunt, Brian T
Prognosis following spontaneous HBsAg seroclearance in chronic hepatitis B patients with or without concurrent infection  Yi–Cheng Chen, I.–Shyan Sheen,
Masatoshi Kudo  Clinical Gastroenterology and Hepatology 
Racial Differences in Survival of Hepatocellular Carcinoma in the United States: A Population-Based Study  Jessica A. Davila, Hashem B. El–Serag  Clinical.
Natural Course of Asymptomatic Hepatitis C Virus–Infected Patients and Hepatocellular Carcinoma After Interferon Therapy  Takeshi Okanoue, Masahito Minami,
Genetics of hepatocellular carcinoma: The next generation
Hepatic oxygen supplementation as therapy in cirrhotic liver disease
Controversies in Liver Transplantation for Hepatitis C
Volume 120, Issue 4, Pages (March 2001)
Volume 156, Issue 4, Pages (March 2019)
Presentation transcript:

Volume 117, Issue 1, Pages 154-160 (July 1999) p53 mutations in British patients with hepatocellular carcinoma: Clustering in genetic hemochromatosis  Guy Vautier*, Adrian B. Bomford‡, Bernard C. Portmann‡, Elizabeth Metivier‡, Roger Williams‡, Stephen D. Ryder*  Gastroenterology  Volume 117, Issue 1, Pages 154-160 (July 1999) DOI: 10.1016/S0016-5085(99)70562-7 Copyright © 1999 American Gastroenterological Association Terms and Conditions

Fig. 1 Site of p53 mutations in 50 British patients with HCC. Gastroenterology 1999 117, 154-160DOI: (10.1016/S0016-5085(99)70562-7) Copyright © 1999 American Gastroenterological Association Terms and Conditions

Fig. 2 Site of mutation within p53 according to origin of liver disease. (A) Alcoholic liver disease; (B) hepatitis C; (C) hemochromatosis; (D) hepatitis B. The frequency of the codon 220 A to G mutation is significantly more frequent in GH-related HCCs than HCCs of other etiologies (P = 0.0001, χ2 test). Gastroenterology 1999 117, 154-160DOI: (10.1016/S0016-5085(99)70562-7) Copyright © 1999 American Gastroenterological Association Terms and Conditions

Fig. 2 Site of mutation within p53 according to origin of liver disease. (A) Alcoholic liver disease; (B) hepatitis C; (C) hemochromatosis; (D) hepatitis B. The frequency of the codon 220 A to G mutation is significantly more frequent in GH-related HCCs than HCCs of other etiologies (P = 0.0001, χ2 test). Gastroenterology 1999 117, 154-160DOI: (10.1016/S0016-5085(99)70562-7) Copyright © 1999 American Gastroenterological Association Terms and Conditions